Gut antibody study aims to unlock Crohn's secrets
NCT ID NCT00769236
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at antibodies in the intestines of 160 people: 80 with Crohn's disease, 40 with ulcerative colitis, and 40 without inflammatory bowel disease. Researchers took blood samples and intestinal biopsies to compare antibody levels in the gut versus the blood. The goal was to see if measuring antibodies directly from the gut could give better information about the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand Crohn's disease and possibly identify different patient groups that need different treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It only looks at antibodies and may not lead to any direct changes in patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Laboratoire d'Immunologie - Hopital de la Conception
Marseille, 13005, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves vs. scope: a gentler way to spot pouch inflammation?
- Can we predict how kids with IBD will respond to treatment?
- AI reads scans to forecast Crohn's complications
- Can stem cell vesicles heal Crohn's fistulas?
- Can a new drug calm the Gut's overactive immune response in Crohn's?
- Can switching IBD meds heal the gut when symptoms are quiet?